10-Q: QDM International Inc. Reports Mixed Results for Quarter Ended September 30, 2024
Quarterly Report
QDM International Inc. experienced a decrease in revenue but an increase in net income for the quarter ended September 30, 2024, compared to the same period last year.
Summary
- QDM International Inc. reported a revenue of $1,020,672 for the three months ended September 30, 2024, a decrease of 12.3% compared to $1,163,726 in the same period of 2023.
- The company's cost of sales significantly decreased by 78.3% to $154,810, down from $713,636 in the same quarter of the previous year, primarily due to lower referral fees.
- Gross profit increased to $865,862, up from $450,090 in the prior year, reflecting a 46.2% increase in gross profit margin.
- General and administrative expenses rose by 120.9% to $273,762, compared to $123,923 in the same quarter of 2023, due to increased hiring and professional fees.
- Net income for the quarter was $488,706, an increase of 81.9% compared to $268,612 in the same period of 2023.
- For the six months ended September 30, 2024, revenue was $1,998,937, a decrease of 54.9% compared to $4,437,013 in the same period of 2023.
- The cost of sales for the six months decreased by 87.4% to $347,442, down from $2,759,717 in the same period of 2023.
- Net income for the six months ended September 30, 2024, was $948,086, a decrease of 21.7% compared to $1,211,254 in the same period of 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative due to the mixed financial results. While net income increased for the quarter, revenue declined significantly, and there are concerns about internal controls and reliance on related party loans. The company is also facing regulatory changes that could impact its business.
Positives
- The company experienced a significant decrease in cost of sales, leading to improved gross profit margins.
- Net income for the three months ended September 30, 2024, increased by 81.9% compared to the same period in 2023.
- The company increased its cooperation with other insurance company partners offering higher basic commission rates.
- The company's cash and cash equivalents increased to $6,298,869 as of September 30, 2024, up from $5,158,223 as of March 31, 2024.
Negatives
- Revenue decreased by 12.3% for the three months and 54.9% for the six months ended September 30, 2024, compared to the same periods in 2023.
- General and administrative expenses increased significantly, impacting overall profitability.
- Net income for the six months ended September 30, 2024, decreased by 21.7% compared to the same period in 2023.
- The company experienced a decrease in net cash inflow from operating activities for the six months ended September 30, 2024, compared to the same period in 2023.
Risks
- The company's revenue is heavily reliant on a few key insurance partners, and a decrease in business from these partners can significantly impact overall revenue.
- The company's internal controls over financial reporting are not effective due to material weaknesses, including lack of proper segregation of duties and formal documentation.
- The company is subject to regulatory changes in Hong Kong that could impact its business operations and referral fee structures.
- The company's reliance on related party loans for working capital poses a risk if these loans are not available in the future.
Future Outlook
The company does not provide specific forward-looking statements or guidance in this report, but it does mention that it will continue to devote resources to remediate material weaknesses in internal controls.
Management Comments
- Management stated that the decrease in revenue was mainly due to a decrease in revenue from their top insurance company partner.
- Management noted that the decrease in cost of sales was primarily due to lower referral fees paid.
- Management indicated that the increase in general and administrative expenses was due to hiring more employees and an increase in professional fees.
- Management expects the prepaid referral fees to be fully credited against referral fees payable by the end of March 31, 2025.
Industry Context
The report indicates that the company operates in the Hong Kong insurance brokerage industry, which is subject to regulatory changes. The company's performance is affected by the dynamics of its relationships with insurance partners and the regulatory environment.
Comparison to Industry Standards
- The company's revenue decline contrasts with the general trend of growth in the insurance brokerage sector, particularly in regions experiencing economic recovery.
- The significant reduction in cost of sales due to lower referral fees is a unique situation, potentially driven by specific regulatory changes in Hong Kong, and may not be typical for the industry.
- The increase in general and administrative expenses is a common trend for growing companies, but the magnitude of the increase may be higher than industry averages.
- The company's net income performance is mixed, with a strong increase in the three-month period but a decrease over the six-month period, which is not consistent with the performance of larger, more established insurance brokers such as Marsh & McLennan or Aon.
Related Party Transactions
- Huihe Zheng, the principal shareholder, CEO, and Chairman, advanced $129,056 to the company during the six months ended September 30, 2024.
- The company issued 6,000,000 Series B Shares to Huihe Zheng in exchange for the cancellation of $600,000 of debt owed to him.
- The due to related party balance with Huihe Zheng was $1,412,277 as of September 30, 2024.
Stakeholder Impact
- Shareholders may be concerned about the decrease in revenue and the material weaknesses in internal controls.
- Employees may be affected by the company's cost-cutting measures and changes in operational strategies.
- Customers may experience changes in service due to the company's shift in focus on different insurance partners.
- Suppliers and creditors may be impacted by the company's financial performance and liquidity.
Next Steps
- The company will continue to remediate material weaknesses in internal controls over financial reporting.
- The company will monitor the impact of regulatory changes on its referral fee structure.
- The company will continue to manage its relationships with insurance partners to optimize revenue.
Key Dates
| Date | Description |
|---|---|
| 2020-10-21 | Share exchange agreement with QDM BVI was entered into. |
| 2021-11-03 | Acquisition of QDMI Software Group Limited. |
| 2023-03-28 | Articles of Amendment filed to increase authorized shares and effect a forward stock split. |
| 2023-10-04 | Sale of QDMS to Mr. Zheng. |
| 2024-04-05 | Forward stock split became effective. |
| 2024-09-30 | End of the quarterly reporting period. |
| 2024-10-04 | Articles of Amendment filed to increase authorized shares of Series B preferred stock. |
| 2024-10-07 | Increase in authorized shares of Series B preferred stock became effective. |
| 2024-10-09 | Securities subscription agreement with Huihe Zheng was entered into. |
| 2024-11-14 | Date of the quarterly report filing. |
Keywords
insurance brokerage, financial results, revenue, net income, cost of sales, Hong Kong, referral fees, operating expenses, financial reporting, internal controls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.